How To Improve the Patients Experience in IO Clinical Trials – with the Gustave Roussy Institute
Cerba Research conducted a case study on patient experience in Immuno Oncology trials at Gustave Roussy’s Cancer Research Center. it is clear that the therapeutic future lies in biomarkers through the development of immunotherapies and companion diagnostics.
Florian Scotté and Adrien Ko, present in the webinar the Patient Connect Solution and the effects expected on the patient pathway in Immuno Oncology trials.
Watch our webinar now to find out more.